BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9366525)

  • 1. Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype.
    Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD; Hiti AL; Gray JW
    Oncogene; 1997 Oct; 15(17):2077-91. PubMed ID: 9366525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies.
    Safarians S; Sternlicht MD; Yamanishi DT; Love SM; Barsky SH
    Cancer Res; 1996 Aug; 56(15):3560-9. PubMed ID: 8758927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.
    Welch DR; Chen P; Miele ME; McGary CT; Bower JM; Stanbridge EJ; Weissman BE
    Oncogene; 1994 Jan; 9(1):255-62. PubMed ID: 8302587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
    Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
    Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
    Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
    Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line.
    Montgomery AM; Mueller BM; Reisfeld RA; Taylor SM; DeClerck YA
    Cancer Res; 1994 Oct; 54(20):5467-73. PubMed ID: 7923181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
    J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential.
    Martínez-Zaguilán R; Martinez GM; Gomez A; Hendrix MJ; Gillies RJ
    J Cell Physiol; 1998 Jul; 176(1):196-205. PubMed ID: 9618159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of C8161 melanoma metastatic ability by chromosome 6 induces differentiation-associated tyrosinase and decreases proliferation on adhesion-restrictive substrates mediated by overexpression of p21WAF1 and down-regulation of bcl-2 and cyclin D3.
    Strasberg Rieber M; Welch DR; Rieber M
    Biochem Biophys Res Commun; 2001 Feb; 281(1):159-65. PubMed ID: 11178974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression.
    Safarians S; Rivera SP; Sternlicht MD; Naeim F; Barsky SH
    Am J Pathol; 1997 Mar; 150(3):949-62. PubMed ID: 9060833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human myoepithelial cell is a natural tumor suppressor.
    Sternlicht MD; Kedeshian P; Shao ZM; Safarians S; Barsky SH
    Clin Cancer Res; 1997 Nov; 3(11):1949-58. PubMed ID: 9815584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell hybridization and neoplastic progression.
    Hart IR
    Symp Fundam Cancer Res; 1983; 36():133-43. PubMed ID: 6382503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
    Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.